Avicanna Inc. (OTCMKTS:AVCNF) Sees Large Decline in Short Interest

Avicanna Inc. (OTCMKTS:AVCNF) saw a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 88,700 shares, a decline of 57.9% from the September 15th total of 210,600 shares. Based on an average daily volume of 104,309 shares, the short-interest ratio is presently 0.9 days.

Avicanna Stock Down 4.1%

Avicanna stock opened at $0.07 on Thursday. The business has a 50 day moving average of $0.08 and a 200-day moving average of $0.09. Avicanna has a 1 year low of $0.06 and a 1 year high of $0.21.

About Avicanna

Avicanna Inc is a biopharmaceutical company focused on the development, manufacture and commercialization of cannabinoid-based products and therapies. The company applies pharmaceutical research and formulation expertise to create products designed for medical, wellness and consumer applications.

Avicanna’s activities include cannabinoid research, cultivation and processing support, product formulation, clinical development and commercialization. Its offerings have included medical cannabis products, pharmaceutical preparations and cannabinoid-based topical and wellness products, including products marketed under the RHO Phyto brand in Canada.

The company has historically maintained operations and commercial relationships in Canada and Colombia, supporting its research, cultivation, manufacturing and distribution activities.